Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Anticancer Research|January 31, 2012
A retrospective study of chemotherapy with and without pemetrexed in malignant pleural mesotheliomaMasayoshi Higashiguchi, Hidekazu Suzuki, Tomonori Hirashima, et al.
Lung|July 25, 2014
A retrospective study of prognostic factors in patients with interstitial pneumonia receiving long-term oxygen therapyMasayoshi Higashiguchi, Takashi Kijima, Hiromitsu Sumikawa, et al.
FEBS Letters|October 8, 2016
Clarifying the biological significance of the CHK2 K373E somatic mutation discovered in The Cancer Genome Atlas databaseMasayoshi Higashiguchi, Izumi Nagatomo, Takashi Kijima, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluidYuhei Kinehara, Takashi Kijima, Koji Inoue, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 17, 2025
Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case reportDaiki Nagira, Satoshi Miyamoto, Taishiro Mizukoshi, et al.
Biochemical and Biophysical Research Communications|May 21, 2017
Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical modelsOsamu Morimura, Toshiyuki Minami, Takashi Kijima, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2015
Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancerYuhei Kinehara, Toshiyuki Minami, Takashi Kijima, et al.
Scientific Reports|September 17, 2013
Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesisToshiyuki Minami, Takashi Kijima, Satoshi Kohmo, et al.
Scientific Reports|March 25, 2018
Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated agingYingji Jin, Yoshito Takeda, Yasushi Kondo, et al.
JCI Insight|December 21, 2018
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cellsYuhei Kinehara, Izumi Nagatomo, Shohei Koyama, et al.
Pageof 2